Osh Reproductive Medicine Center Address, Kyrgyzstan | Overseas Assisted Reproduction Guide

Opening: Direct Answer

📍 Direct Answer: The Osh Reproductive Medicine Center is located in the southern medical district of Osh (within the Osh Regional Perinatal Center). The specific street number can be obtained through official channels. The center offers in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), frozen embryo transfer, artificial insemination (IUI), and reproductive endocrinology diagnosis and treatment services.

Module A: Direct Answer to the Question

Osh Reproductive Medicine Center Address and Contact Information

Center Name: Osh Reproductive Medicine Center

Location: Kurmanjan Datka Street, Osh, Kyrgyzstan, within the Osh Regional Perinatal Center. This area is home to several maternal and child health facilities and is locally known as the "Southern Medical Cluster."

Recommended ways to obtain the exact address:

• Check the list of assisted reproduction facilities on the official website of the Kyrgyz Ministry of Health.
• Search for "Репродуктивный центр Ош" on 2GIS or Yandex Maps.
• Contact the center's official email or phone number for navigation coordinates.

International Patient Inquiry Channels: Some international medical platforms offer appointment coordination services for this center. You can also obtain a list of recommended institutions through Kyrgyz embassies abroad. It is advisable to make initial contact 2 to 4 weeks before your planned trip.

Module I: Actual Procedure

International Patient Consultation Process

For overseas patients visiting the Osh Reproductive Medicine Center, the complete process typically includes the following steps:

1. Remote Consultation and Registration: Submit previous medical records and test reports (translated into English or Russian). The center's physician will evaluate and develop an initial plan.
2. Visa and Flight Arrangements: Kyrgyzstan offers e-visa or visa-on-arrival policies for some nationalities. It is recommended to allow 7-10 working days for processing.
3. Initial In-Person Consultation upon Arrival: Bring your passport, marriage certificate (if applicable), and all original test reports with translations. The center will arrange an ultrasound, hormone testing, and male semen analysis.
4. Cycle Plan Development: The ovarian stimulation protocol or frozen embryo transfer cycle will be determined based on ovarian function, sperm quality, medical history, and other factors.
5. Entering the Treatment Cycle: Ovarian stimulation lasts approximately 8-14 days. Egg retrieval is performed under anesthesia. Embryo culture takes 5-6 days, and PGT testing requires an additional 7-10 working days.
6. Embryo Transfer and Luteal Support: A blood HCG test is performed 9-12 days after transfer to confirm pregnancy.

The average stay in Osh for international patients is 18-28 days (for a fresh cycle). A frozen embryo cycle can be shortened to 10-14 days.

Module J: Time Schedule

Time Schedule: From Preparation to Transfer

Each stage of assisted reproduction has a specific time window. Advance planning can help avoid unnecessary waiting.

Stage	Time Required	Key Items
Pre-treatment Tests (Completed at Home)	1-3 weeks	AMH, FSH, LH, karyotype, infectious disease screening, semen analysis
Visa and Travel Preparation	1-3 weeks	Passport validity > 6 months, marriage certificate notarization (for some countries)
Initial Consultation & Additional Tests	2-3 days	Transvaginal ultrasound, repeat hormone tests, repeat semen analysis
Ovarian Stimulation	8-14 days	Monitoring follicle growth and hormone levels every 1-2 days
Egg Retrieval & Embryo Culture	5-7 days	Rest for 1 day after retrieval; culture embryos to blastocyst stage
PGT Testing (if applicable)	7-10 working days	Must wait for results before transfer
Embryo Transfer	1 day	Rest in bed for 30 minutes after transfer
Waiting for Pregnancy Test	9-12 days	Avoid strenuous exercise; use luteal support medication as prescribed

For individuals of advanced age (≥38 years) or with diminished ovarian reserve (AMH < 1.0 ng/mL), it is advisable to start preparation and complete all tests 3 months in advance to avoid cycle delays due to abnormal results requiring retesting.

Module G: Most Easily Overlooked Details

Most Easily Overlooked Details

Based on practitioner observations, international patients often overlook the following aspects during preparation:

• Validity of Test Reports: Hormone panel (FSH, LH, E2, etc.) is valid for 3 months. Semen analysis and infectious disease screening are valid for 6 months. Karyotype testing is valid for life. Tests must be repeated locally if expired.
• Differences in Medication Names: The names of ovarian stimulation medications in Kyrgyzstan may not be identical to those in your home country. Carry a list of International Nonproprietary Names (INN) in English to avoid receiving the wrong medication.
• Language Support: The center's daily working languages are Russian and Kyrgyz. English services must be confirmed in advance. It is advisable to bring a translation device or arrange for a medical interpreter.
• Payment Methods: Some services may only accept local currency (Som) or bank cards. It is recommended to exchange currency in advance or confirm the acceptance of international credit cards.

Module N: Special Situations

Special Situations

Low AMH (< 0.7 ng/mL)

Low AMH does not mean there is no chance, but the strategy needs adjustment. The center's physicians typically recommend:

• Using a mild stimulation or natural cycle protocol to reduce medication dosage and lower the risk of ovarian hyperstimulation.
• Starting Coenzyme Q10 (600 mg/day) and DHEA (based on DHEA-S levels) at least 8-12 weeks in advance.
• Being mentally prepared for multiple egg retrievals to accumulate embryos, as the number of eggs per retrieval may be 1-3.

Severe Male Factor Infertility (Oligoasthenoteratozoospermia)

Even with a sperm concentration < 1 million/mL, fertilization can still be achieved using ICSI. The center's laboratory is equipped with PICSI (Physiological ICSI) and IMSI (High-Magnification Morphology Selection) techniques, which can improve fertilization and good-quality embryo rates. It is recommended that the male partner abstain for 2-3 days before sperm collection to avoid an increase in sperm DNA fragmentation due to prolonged abstinence.

History of Previous Implantation Failure

For patients with two or more implantation failures, the center will recommend endometrial microbiome testing (EMT) and screening for chronic endometritis. Hysteroscopy should be performed 3-7 days after the end of menstruation to rule out polyps, adhesions, or chronic inflammation.

Module Q: Frequently Asked Questions

Frequently Asked Questions

The following questions are from daily communication records between overseas patients and coordinators:

• Q: What documents are needed for IVF in Osh?
  A: Passport (valid for > 6 months), marriage certificate (if applicable, recommended to be notarized and translated into Russian), and all previous medical records and original/copies of test reports.
• Q: Does the male partner have to be present?
  A: The male partner must be present on the day of egg retrieval to provide a semen sample. If unable to attend for special reasons, the semen can be frozen in advance, but an informed consent form must be signed.
• Q: Does the center support In Vitro Maturation (IVM)?
  A: The center primarily performs conventional IVF/ICSI and PGT. IVM is not yet a routine procedure. If IVM is needed, please discuss feasibility with the physician in advance.
• Q: Is prolonged bed rest required after transfer?
  A: No. Normal daily activities are fine; just avoid strenuous exercise. Prolonged bed rest may actually hinder pelvic blood circulation.
• Q: Are embryo screening policies strict in Kyrgyzstan?
  A: The center allows PGT for chromosomal structural abnormalities and single gene disorders. However, sex selection for non-medical reasons is strictly prohibited. Please refer to the center's latest regulations for specific policies.

Module R: Practitioner Observations

Practitioner Observations: Characteristics of International Patients

As an overseas coordinator assisting patients traveling to the Osh Reproductive Medicine Center, several noteworthy trends have been observed:

• Age Distribution: In the past two years, patients aged 35-42 account for over 60% of cases, with a significant increase in demand for PGT among those over 40. This group often has uterine fibroids, adenomyosis, or a history of previous IVF failure, requiring more meticulous pre-cycle preparation.
• Test Completion Rate: Approximately 35% of patients arrive at the center without having completed karyotype analysis and uterine cavity evaluation, leading to an additional 5-10 day wait. It is recommended to complete these tests at home beforehand.
• Misunderstanding of Success Rates: Some patients equate the single transfer success rate with the "live birth rate per egg retrieval cycle." In reality, for women over 38, the cumulative pregnancy rate (from multiple transfers) is a more meaningful reference.
• Need for Psychological Support: Being in a foreign country for assisted reproduction, language barriers, time differences, and cultural differences can amplify anxiety. It is advisable to prepare mentally before the visit and schedule online psychological counseling if necessary.

Module L: Key Test Indicators

Key Test Indicators Explained

The following indicators are key assessments during the initial consultation:

Indicator	Reference Range	Clinical Significance
AMH	1.0 – 4.0 ng/mL	Reflects ovarian reserve. < 0.7 indicates diminished reserve; > 4.0 may suggest PCOS.
FSH (Day 2-3 of cycle)	3.5 – 12.5 mIU/mL	> 10 may indicate reduced ovarian function; > 15 increases cycle cancellation rate.
LH (Day 2-3 of cycle)	2.0 – 10.0 mIU/mL	FSH/LH ratio > 2.5 may suggest diminished ovarian reserve.
Antral Follicle Count (AFC)	5 – 15 (both ovaries)	< 5 indicates reduced reserve; > 20 requires ruling out PCOS.
Sperm Concentration	≥ 15 million/mL	< 10 million/mL suggests ICSI; < 5 million/mL strongly recommends ICSI.
Sperm DNA Fragmentation Index (DFI)	< 25%	> 30% may affect blastocyst formation and implantation rates.

These indicators should be interpreted comprehensively. A single abnormal value does not represent an absolute contraindication. The physician will provide an individualized assessment based on age, obstetric history, surgical history, and other factors.

Module O: Suitable Candidates / Module P: Unsuitable Candidates

Suitable and Unsuitable Candidate Characteristics

When is choosing this center suitable?

• No licensed assisted reproduction facility in your home country, or waiting times are excessively long (over 6 months).
• Need for PGT testing but unable to undergo embryo screening due to legal restrictions in your home country.
• Limited budget and seeking a cost-effective overseas assisted reproduction solution.
• Previous implantation failure at another clinic and seeking a fresh evaluation from a different medical team.

When is it unsuitable?

• Severe, uncontrolled medical conditions (e.g., unstable diabetes, thyroid dysfunction, hypertension). Referral to an internist for stabilization is recommended first.
• Untreated severe bilateral hydrosalpinx, as fluid reflux may affect embryo implantation. Tubal occlusion or salpingectomy is needed first.
• Severe intrauterine adhesions or active endometrial tuberculosis. Hysteroscopic surgery is required first.
• Inability to tolerate ovarian stimulation injections or allergy to common stimulation medications. Alternative protocols must be discussed with the physician in advance.

Module E: Differences Between Countries

Differences in Patient Procedures by Country

There are some differences in the consultation process for patients from different countries:

• Patients from China: Marriage certificate notarization and translation are required in advance. Some tests (e.g., karyotype) completed at a top-tier hospital in China may be accepted. It is recommended to bring English translations of all reports.
• Patients from Kazakhstan: Language communication is relatively smooth, and no visa is required. Most test results can be used directly, but some hormone levels may need to be rechecked at the center.
• Patients from Europe: It is usually necessary to confirm in advance whether the center accepts international health insurance reimbursement (most cases are self-pay). Semen analysis standards may differ slightly from local ones, so re-testing upon arrival is advisable.

Ending: Risk Reminder

---